First human test: new apathy drug given to elderly volunteers
NCT ID NCT06699628
Summary
This early-stage study tested how a new drug called IRL757 moves through and is processed by the body. Twelve healthy volunteers aged 65 and older received a single oral dose to measure drug levels in their blood and urine over time. The main goal was to understand the drug's safety profile and how it behaves in older adults before testing it in patients with apathy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC Clinical Trial Consultants AB
Uppsala, Sweden
Conditions
Explore the condition pages connected to this study.